Galapagos
Europe, Limburg, Belgium, Mechelen-bovelingen
Description
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Investor Profile
Galapagos has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands, France.
- Strong thematic focus on Biotechnology, Life Science, Biopharma.
Stage Focus
- Seed (67%)
- Series C (33%)
Country Focus
- United States (33%)
- The Netherlands (33%)
- France (33%)
Industry Focus
- Biotechnology
- Life Science
- Biopharma
- Pharmaceutical
- Precision Medicine
- Health Care
- Therapeutics
- Health Diagnostics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Galapagos frequently co-invest with?
What are some of recent deals done by Galapagos?
Find More Investors Like Galapagos
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
